RCRobert Coleman

Robert Coleman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert Coleman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterization of optothermal transition dynamics in Ge 2 Sb 2 Te 5 and Sb 2 Te 3 via spatial light modulation microscopy

    by Robert E. Coleman, Malcolm Bogroff, Seppe Van Dyck, Christophe Detavernier, Sami Znati, Parsian K. Mohseni, Eric Seabron

    We present a confocal microscopy-based method for constructing power-dependent optothermal transition (OTT) diagrams of phase-change chalcogenide (PCC) thin films via spatial light modulation, without diffraction-limited optics, pulse shaping, or temporal modulation. Optical dosage is engineered through controlled scanning dynamics to systematically map amorphous, crystalline, semi-crystalline, and failure regimes in Ge 2 Sb 2 Te 5 and Sb 2 Te 3 on silicon and silicon-on-insulator substrates. Substrate-dependent transition setpoints and cycling behavior are identified and supported by optothermal simulations, while failure mechanisms, including delamination and dewetting, are experimentally resolved through spatially mapped optical measurements. Reproducible intermediate optical states are achieved through controlled variations in incident power and exposure count. Integration of two-photon excitation fluorescence and second-harmonic generation probes enable single-step discrimination between phase transitions and degradation, while revealing dynamic nonlinear behavior within the crystalline phase. This scalable optical platform advances PCC materials characterization and programming for photonic memory and reconfigurable integrated photonics.

  • Open Access

    ManQala: Game-inspired strategies for quantum state engineering

    by Onur Danaci, Wenlei Zhang, Robert Coleman, William Djakam, Michaela Amoo, Ryan T. Glasser, Brian T. Kirby, Moussa N'GOm, Thomas A. Searles

    The ability to prepare systems in specific target states through quantum engineering is essential for realizing the new technologies promised by a second quantum revolution. Here, we recast the fundamental problem of state preparation in high-dimensional Hilbert spaces as ManQala, a quantum game inspired by the West African sowing game mancala. Motivated by optimal gameplay in solitaire mancala, where nested nearest-neighbor permutations and actions evolve the state of the game board to its target configuration, ManQala acts as a pre-processing approach for deterministically arranging particles in a quantum control problem. Once pre-processing with ManQala is complete, existing quantum control methods are applied, but now with a reduced search space. We find that ManQala-type strategies match, or outperform, competing approaches in terms of final state variance even in small-scale quantum state engineering problems where we expect the slightest advantage, since the relative reduction in search space is the least. These results suggest that ManQala provides a rich platform for designing control protocols relevant to quantum technologies.


  • Efficacy and Cost-Effectiveness of Antibiotic Monitoring at a Veterans Administration Hospital

    by Peter O’hArtley, L. Rodondi, R. Coleman

    A rigorous, continuously monitored antibiotic programme was initiated at our Veterans Administration hospital following evidence of inappropriate antibiotic usage. Seven hundred and thirty-one patients, mainly male, with an average age of 60 years were involved in the study; 378 were evaluable prior to policy implementation and 273 subsequently. The overall prevalence of deaths and average length of antibiotic therapy were less during the post-policy period. The number of antibiotic doses per patient was decreased by 24%. Drug costs were reduced by 32% post-policy, due largely to increased use of the longer-acting cephalosporins ceftriaxone and cefotetan. A 23% reduction in antibiotic acquisition costs was achieved over the 3-year period of the study, without detrimental effects on patient outcome.